Halil Serdar Aslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Halil Serdar Aslan has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Muhammet Arslan
Pamukkale Universitesi
13 shared publications - Kadir Han Alver
Pamukkale University Faculty of Medicine, Department of Radiology, Denizli, Türkiye
11 shared publications - Mahmut Demirci
Department of Radiology/Interventional Radiology, Faculty of Medicine, Adnan Menderes University Hospital, Adnan Menderes University, Aydın, Turkey
7 shared publications - Muhammed Tekinhatun
Department of Radiology, Dicle University Medical Faculty, Diyarbakır, Turkey
5 shared publications - Ayse Ruksan Utebey
Pamukkale University, Denizli, Turkey
3 shared publications - Sercan Vurgun
Department of Radiology, School of Medicine, Pamukkale University, 20700 Denizli, Turkiye
3 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 641-652
Factors Affecting Cholecystostomy Tube Removal and Interval Cholecystectomy Timing After Percutaneous Cholecystostomy for Acute Cholecystitis
Background:Percutaneous cholecystostomy (PC) is widely used. It is used in high-risk patients with acute cholecystitis. These patients are not suitable for immediate surgery. However, the optimal timing for removing the cholecystostomy tube and performing subsequent interval cholecystectomy (IC) remains controversial. This study aimed to evaluate factors affecting PC tube removal time and IC timing, and to identify predictors associated with operative outcomes.Methods:This retrospective, single-centre study included patients who underwent percutaneous cholecystostomy for acute cholecystitis between 2015 and 2025. The following data were analysed: demographic characteristics, comorbidity burden, American Society of Anesthesiologists (ASA) scores, Tokyo 2018 acute cholecystitis grade, gallbladder perforation, operative status, surgical approach and mortality. Factors associated with cholecystostomy tube removal time and IC timing were evaluated using comparative and regression analyses.Results:A total of 102 patients were included in the study, with an average age of 64.4 ± 15.4 years. Interval cholecystectomy was performed in 71 patients (69.6%), while 31 patients (30.4%) were managed non-operatively. Patients who underwent surgery were significantly younger and had lower ASA scores and Charlson Comorbidity Index values compared with those who did not undergo surgery (p
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 641-652
Open AccessFactors Affecting Cholecystostomy Tube Removal and Interval Cholecystectomy Timing After Percutaneous Cholecystostomy for Acute Cholecystitis
Background:Percutaneous cholecystostomy (PC) is widely used. It is used in high-risk patients with acute cholecystitis. These patients are not suitable for immediate surgery. However, the optimal timing for removing the cholecystostomy tube and performing subsequent interval cholecystectomy (IC) remains controversial. This study aimed to evaluate factors affecting PC tube removal time and IC timing, and to identify predictors associated with operative outcomes.Methods:This retrospective, single-centre study included patients who underwent percutaneous cholecystostomy for acute cholecystitis between 2015 and 2025. The following data were analysed: demographic characteristics, comorbidity burden, American Society of Anesthesiologists (ASA) scores, Tokyo 2018 acute cholecystitis grade, gallbladder perforation, operative status, surgical approach and mortality. Factors associated with cholecystostomy tube removal time and IC timing were evaluated using comparative and regression analyses.Results:A total of 102 patients were included in the study, with an average age of 64.4 ± 15.4 years. Interval cholecystectomy was performed in 71 patients (69.6%), while 31 patients (30.4%) were managed non-operatively. Patients who underwent surgery were significantly younger and had lower ASA scores and Charlson Comorbidity Index values compared with those who did not undergo surgery (p
- Open Access
- 13 April 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (2) , 331-340
Percutaneous endobiliary ablation (RFA and MWA) prior to stenting: assessing feasibility and outcomes in malignant biliary obstruction
Purpose: This study aims to evaluate the feasibility and effectiveness of percutaneous endobiliary Microwave Ablation (MWA) and Radiofrequency Ablation (RFA) prior to metallic stent placement for managing symptomatic, unresectable malignant biliary obstructions (MBOs).Materials and methods: We conducted a retrospective cohort analysis of 122 patients diagnosed with malignant tumors causing biliary obstructions, comparing outcomes between those receiving stents only and those undergoing prior ablation. Data collected included patient demographics, procedural details, complication rates, stent patency, and overall survival.Results: Among the 122 patients, 101 received stents alone, while 21 underwent ablation (13 with MWA and 8 with RFA). There was no significant difference in stent patency duration (255.7 days for ablation vs. 219.6 days for stent-only, p=0.218) or overall survival (average of 123 days, p=0.105). The complication rate was significantly higher in the ablation group (p=0.023).Conclusion: While endobiliary ablative treatments before metallic stenting appear feasible for palliative care of unresectable MBOs, our findings indicate no significant improvement in stent patency or overall survival. Further randomized controlled studies are necessary to clarify the efficacy and necessity of these techniques.
- 13 April 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (2) , 331-340
Open AccessPercutaneous endobiliary ablation (RFA and MWA) prior to stenting: assessing feasibility and outcomes in malignant biliary obstruction
Purpose: This study aims to evaluate the feasibility and effectiveness of percutaneous endobiliary Microwave Ablation (MWA) and Radiofrequency Ablation (RFA) prior to metallic stent placement for managing symptomatic, unresectable malignant biliary obstructions (MBOs).Materials and methods: We conducted a retrospective cohort analysis of 122 patients diagnosed with malignant tumors causing biliary obstructions, comparing outcomes between those receiving stents only and those undergoing prior ablation. Data collected included patient demographics, procedural details, complication rates, stent patency, and overall survival.Results: Among the 122 patients, 101 received stents alone, while 21 underwent ablation (13 with MWA and 8 with RFA). There was no significant difference in stent patency duration (255.7 days for ablation vs. 219.6 days for stent-only, p=0.218) or overall survival (average of 123 days, p=0.105). The complication rate was significantly higher in the ablation group (p=0.023).Conclusion: While endobiliary ablative treatments before metallic stenting appear feasible for palliative care of unresectable MBOs, our findings indicate no significant improvement in stent patency or overall survival. Further randomized controlled studies are necessary to clarify the efficacy and necessity of these techniques.
- 28 January 2026
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Developments and Experiments in Health and Medicine
- Vol. 40 (1) , 123-136
Efficacy and safety of bleomycin–lipiodol transarterial chemoembolization in giant hepatic hemangiomas: Insights from a single-center experience
BACKGROUND This study aimed to evaluate the efficacy and safety of bleomycin–lipiodol transarterial chemoembolization in the treatment of giant hepatic hemangiomas based on data from our center and to assess volumetric changes in non-target hemangiomas, as well as the contribution of a coil-assisted superselective approach to procedural safety. METHODS Retrospective data from 23 patients who underwent bleomycin–lipiodol transarterial chemoembolization for the treatment of giant hepatic hemangiomas between October 2018 and December 2024 were analyzed. Target hemangioma volumes were calculated before the procedure and at 6 months of follow-up. Clinical success was defined as ≥ 50% volume reduction on ultrasonography at 6 months. Non-target hemangiomas were evaluated at mid- and long-term follow-up. Detachable mechanical coil embolization was performed for 4 patients to prevent reflux and vasospasm in the non-lesional parenchyma. Complications were classified according to Cardiovascular and Interventional Radiological Society of Europe standards. RESULTS The mean age of the patients was 51.2 ± 8.6 years, and 19 (82.6%) were female. No major complications or mortality were observed; minor complications occurred in 3 patients (13%). At 6 months, the mean volume reduction rate was 54.2 ± 11.3% (p < 0.001). Clinical success was achieved in 20 cases (87.0%). Volume reduction increased with longer follow-up, reaching 83% at 24 months and 94% at ≥ 36 months. Among 10 patients with multiple hemangiomas, non-target lesions demonstrated an average 85% reduction in volume in mid- to long-term follow-up evaluations. CONCLUSION Bleomycin–lipiodol transarterial chemoembolization is a safe and effective treatment for giant hepatic hemangiomas, achieving high efficacy with low morbidity. The treatment provides significant volume reduction not only in target lesions but also in non-target hemangiomas, suggesting a potential locoregional or diffuse pharmacological effect beyond the directly embolized area. Coil-assisted superselective embolization substantially enhances procedural safety. Bleomycin, embolization, eemangioma, lipiodol, liver
- 28 January 2026
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Developments and Experiments in Health and Medicine
- Vol. 40 (1) , 123-136
Efficacy and safety of bleomycin–lipiodol transarterial chemoembolization in giant hepatic hemangiomas: Insights from a single-center experience
BACKGROUND This study aimed to evaluate the efficacy and safety of bleomycin–lipiodol transarterial chemoembolization in the treatment of giant hepatic hemangiomas based on data from our center and to assess volumetric changes in non-target hemangiomas, as well as the contribution of a coil-assisted superselective approach to procedural safety. METHODS Retrospective data from 23 patients who underwent bleomycin–lipiodol transarterial chemoembolization for the treatment of giant hepatic hemangiomas between October 2018 and December 2024 were analyzed. Target hemangioma volumes were calculated before the procedure and at 6 months of follow-up. Clinical success was defined as ≥ 50% volume reduction on ultrasonography at 6 months. Non-target hemangiomas were evaluated at mid- and long-term follow-up. Detachable mechanical coil embolization was performed for 4 patients to prevent reflux and vasospasm in the non-lesional parenchyma. Complications were classified according to Cardiovascular and Interventional Radiological Society of Europe standards. RESULTS The mean age of the patients was 51.2 ± 8.6 years, and 19 (82.6%) were female. No major complications or mortality were observed; minor complications occurred in 3 patients (13%). At 6 months, the mean volume reduction rate was 54.2 ± 11.3% (p < 0.001). Clinical success was achieved in 20 cases (87.0%). Volume reduction increased with longer follow-up, reaching 83% at 24 months and 94% at ≥ 36 months. Among 10 patients with multiple hemangiomas, non-target lesions demonstrated an average 85% reduction in volume in mid- to long-term follow-up evaluations. CONCLUSION Bleomycin–lipiodol transarterial chemoembolization is a safe and effective treatment for giant hepatic hemangiomas, achieving high efficacy with low morbidity. The treatment provides significant volume reduction not only in target lesions but also in non-target hemangiomas, suggesting a potential locoregional or diffuse pharmacological effect beyond the directly embolized area. Coil-assisted superselective embolization substantially enhances procedural safety. Bleomycin, embolization, eemangioma, lipiodol, liver
- Open Access
- 8 December 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (4) , 479-486
Impact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy
Impact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy - Diagnostic and Interventional Radiology
- 8 December 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (4) , 479-486
Open AccessImpact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy
Impact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy - Diagnostic and Interventional Radiology
- 28 August 2025
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 12 (2) , 99-104
The Role of Coronary Computed Tomography Angiography in Detecting Coronary Artery Stenosis
The aim of this study is to evaluate the role of Coronary Computed Tomography Angiography, a minimally invasive imaging method, in detecting coronary artery stenosis. This study retrospectively analyzed the coronary artery segments of 66 patients who underwent both Conventional Coronary Angiography and Coronary Computed Tomography Angiography at Ondokuz Mayıs University Hospital between May 2005 and November 2007. These patients were referred with indications such as angina pectoris, stent evaluation, or suspected coronary artery disease. Coronary artery segments were categorized into proximal, mid, and distal groups using the classification system defined by the American Heart Association. The degree of stenosis was evaluated based on the following classification: mild (1–49%), significant (50–74%), advanced (75–99%), and total occlusion (100%). The data obtained from Coronary Computed Tomography Angiography were retrospectively compared with the findings from Conventional Coronary Angiography. According to these findings, the sensitivity and specificity of Coronary Computed Tomography Angiography across all groups were calculated as 87% and 97%, respectively. Atherosclerotic changes in proximal segments led to a decrease in specificity, while difficulties in assessing distal segments resulted in reduced sensitivity. These results demonstrate that Coronary Computed Tomography Angiography, as supported by the literature, is a promising alternative method for detecting coronary artery stenosis. With advancements in technology, it is poised to become an effective tool for diagnosing coronary artery disease, which is rapidly increasing in prevalence in industrialized societies, and for screening asymptomatic patients who are at risk.
- 28 August 2025
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 12 (2) , 99-104
The Role of Coronary Computed Tomography Angiography in Detecting Coronary Artery Stenosis
The aim of this study is to evaluate the role of Coronary Computed Tomography Angiography, a minimally invasive imaging method, in detecting coronary artery stenosis. This study retrospectively analyzed the coronary artery segments of 66 patients who underwent both Conventional Coronary Angiography and Coronary Computed Tomography Angiography at Ondokuz Mayıs University Hospital between May 2005 and November 2007. These patients were referred with indications such as angina pectoris, stent evaluation, or suspected coronary artery disease. Coronary artery segments were categorized into proximal, mid, and distal groups using the classification system defined by the American Heart Association. The degree of stenosis was evaluated based on the following classification: mild (1–49%), significant (50–74%), advanced (75–99%), and total occlusion (100%). The data obtained from Coronary Computed Tomography Angiography were retrospectively compared with the findings from Conventional Coronary Angiography. According to these findings, the sensitivity and specificity of Coronary Computed Tomography Angiography across all groups were calculated as 87% and 97%, respectively. Atherosclerotic changes in proximal segments led to a decrease in specificity, while difficulties in assessing distal segments resulted in reduced sensitivity. These results demonstrate that Coronary Computed Tomography Angiography, as supported by the literature, is a promising alternative method for detecting coronary artery stenosis. With advancements in technology, it is poised to become an effective tool for diagnosing coronary artery disease, which is rapidly increasing in prevalence in industrialized societies, and for screening asymptomatic patients who are at risk.
- Open Access
- 26 April 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (11) , 5537-5551
US-Guided percutaneous core needle biopsy via the complete transhepatic approach: a reliable option for deep abdominal lesions
Purpose: To assess the feasibility, reliability, and diagnostic performance of ultrasound (US)-guided percutaneous core needle biopsy (PCNB) performed via the complete transhepatic approach (CTHa) for abdominal lesions. Materials and methods: This study included 71 patients (31 males, 40 females) with a mean age of 64.8 ± 13.9 years (range: 19–93) who underwent US-guided PCNB via the CTHa for abdominal lesions between January 2014 and December 2024. All biopsies were performed by interventional radiologists with at least five years of experience using a coaxial system and an 18-gauge automatic biopsy device. Patients were assessed for technical success, diagnostic yield, and complications, which were classified as major or minor based on the Society of Interventional Radiology (SIR) guidelines. Results: Tissue samples were successfully obtained in all cases, achieving a 100% technical success rate. Adequate material for pathological diagnosis was available in 63 of 71 patients (88.7%), while a definitive diagnosis could not be established in 11.3% of cases. Diagnostic yield was significantly influenced by lesion type (solid or mixed with cystic components) and anatomical location ( p = 0.001 and p = 0.032, respectively). Complications occurred in 12.7% of patients, including 11.3% minor and 1.4% major complications. Univariate logistic regression analysis identified a history of malignancy, lesion size along the biopsy path, and the length of liver parenchyma traversed as significant predictors of complications ( p = 0.012, 0.027 and 0.003 respectively). In the multivariate model, liver parenchyma length remained the only independent risk factor ( p = 0.023). Conclusion: US-guided PCNB via the CTHa is a safe and effective option for abdominal lesions when extrahepatic access is not feasible. While longer liver tissue traversal increases the risk of minor complications, no major adverse events were observed. Careful procedural planning and consideration of lesion location and cystic content are essential to optimize diagnostic yield. Graphical
- 26 April 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (11) , 5537-5551
Open AccessUS-Guided percutaneous core needle biopsy via the complete transhepatic approach: a reliable option for deep abdominal lesions
Purpose: To assess the feasibility, reliability, and diagnostic performance of ultrasound (US)-guided percutaneous core needle biopsy (PCNB) performed via the complete transhepatic approach (CTHa) for abdominal lesions. Materials and methods: This study included 71 patients (31 males, 40 females) with a mean age of 64.8 ± 13.9 years (range: 19–93) who underwent US-guided PCNB via the CTHa for abdominal lesions between January 2014 and December 2024. All biopsies were performed by interventional radiologists with at least five years of experience using a coaxial system and an 18-gauge automatic biopsy device. Patients were assessed for technical success, diagnostic yield, and complications, which were classified as major or minor based on the Society of Interventional Radiology (SIR) guidelines. Results: Tissue samples were successfully obtained in all cases, achieving a 100% technical success rate. Adequate material for pathological diagnosis was available in 63 of 71 patients (88.7%), while a definitive diagnosis could not be established in 11.3% of cases. Diagnostic yield was significantly influenced by lesion type (solid or mixed with cystic components) and anatomical location ( p = 0.001 and p = 0.032, respectively). Complications occurred in 12.7% of patients, including 11.3% minor and 1.4% major complications. Univariate logistic regression analysis identified a history of malignancy, lesion size along the biopsy path, and the length of liver parenchyma traversed as significant predictors of complications ( p = 0.012, 0.027 and 0.003 respectively). In the multivariate model, liver parenchyma length remained the only independent risk factor ( p = 0.023). Conclusion: US-guided PCNB via the CTHa is a safe and effective option for abdominal lesions when extrahepatic access is not feasible. While longer liver tissue traversal increases the risk of minor complications, no major adverse events were observed. Careful procedural planning and consideration of lesion location and cystic content are essential to optimize diagnostic yield. Graphical
- Open Access
- 20 March 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (1) , 28-33
Efficacy, safety, and short-term follow-up results of CT-guided radiofrequency and microwave ablation in the treatment of Osteoid Osteoma
Introduction: The use of Computed Tomography-guided (CT-guided) percutaneous thermal ablation (PTA) techniques in the treatment of osteoid osteoma (OO) has been increasingly adopted worldwide. This study aims to evaluate the efficacy and safety of thermal ablation techniques in OO treatment, with a particular focus on short-term clinical success rates. Methods: A retrospective analysis was conducted on 19 patients who underwent radiofrequency ablation (RFA) or microwave ablation (MWA) CT-guided in the Interventional Radiology Department of Pamukkale University Faculty of Medicine Hospital between October 2018 and December 2024. Data were obtained from hospital records. All procedures were performed under sedation by a single interventional radiologist, and follow-up evaluations were recorded on post-procedure day 1 and month 1. Visual Analog Scale (VAS) scores and lesion characteristics were reviewed from medical records. Technical success was defined as complete ablation of the nidus, while clinical success was defined as a post-procedure VAS score of ≤3. Results: The mean age of the 19 patients who underwent thermal ablation was 13.6 years. Of the cohort, 36.8% (n=7) were female, and 63.2% (n=12) were male. The mean nidus diameter was 4.57 mm. The mean pre-procedure VAS score was 8.32, which significantly decreased to 1.11 on the first day post-procedure and 0.37 at the first-month follow-up. The technical success rate was 100%, while the clinical success rate was 95%. Minor complications were observed in 10.53% of cases, and major complications were reported in 5.26% of cases. Subgroup analyses revealed significant differences in pain perception between pediatric and adolescent patients before the procedure, but all groups showed statistically significant reductions in VAS scores post-procedure. Conclusion: CT-guided PTA techniques are effective, safe, and minimally invasive treatment options for osteoid osteoma. In addition to high technical and clinical success rates, they offer a rapid recovery period. The findings support the use of PTA techniques as a first-line treatment option for OO. However, due to the retrospective study design, larger, multi-center, prospective randomized studies are required to confirm and expand these findings.
- 20 March 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (1) , 28-33
Open AccessEfficacy, safety, and short-term follow-up results of CT-guided radiofrequency and microwave ablation in the treatment of Osteoid Osteoma
Introduction: The use of Computed Tomography-guided (CT-guided) percutaneous thermal ablation (PTA) techniques in the treatment of osteoid osteoma (OO) has been increasingly adopted worldwide. This study aims to evaluate the efficacy and safety of thermal ablation techniques in OO treatment, with a particular focus on short-term clinical success rates. Methods: A retrospective analysis was conducted on 19 patients who underwent radiofrequency ablation (RFA) or microwave ablation (MWA) CT-guided in the Interventional Radiology Department of Pamukkale University Faculty of Medicine Hospital between October 2018 and December 2024. Data were obtained from hospital records. All procedures were performed under sedation by a single interventional radiologist, and follow-up evaluations were recorded on post-procedure day 1 and month 1. Visual Analog Scale (VAS) scores and lesion characteristics were reviewed from medical records. Technical success was defined as complete ablation of the nidus, while clinical success was defined as a post-procedure VAS score of ≤3. Results: The mean age of the 19 patients who underwent thermal ablation was 13.6 years. Of the cohort, 36.8% (n=7) were female, and 63.2% (n=12) were male. The mean nidus diameter was 4.57 mm. The mean pre-procedure VAS score was 8.32, which significantly decreased to 1.11 on the first day post-procedure and 0.37 at the first-month follow-up. The technical success rate was 100%, while the clinical success rate was 95%. Minor complications were observed in 10.53% of cases, and major complications were reported in 5.26% of cases. Subgroup analyses revealed significant differences in pain perception between pediatric and adolescent patients before the procedure, but all groups showed statistically significant reductions in VAS scores post-procedure. Conclusion: CT-guided PTA techniques are effective, safe, and minimally invasive treatment options for osteoid osteoma. In addition to high technical and clinical success rates, they offer a rapid recovery period. The findings support the use of PTA techniques as a first-line treatment option for OO. However, due to the retrospective study design, larger, multi-center, prospective randomized studies are required to confirm and expand these findings.
- Open Access
- 26 February 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 1-15
Predictive factors for spontaneous dislodgement of percutaneous nephrostomies for malignant ureteral obstruction
Purpose: To investigate the etiology of spontaneous percutaneous nephrostomy (PCN) catheter dislodgements and evaluate factors potentially associated with these dislodgements, including muscle-to-fat composition and tissue characteristics of catheter traces. Materials and methods: Data from 92 patients (63 males, 29 females; mean age 63.9 ± 11.4 years, range 28–88) undergoing 151 PCN catheter replacements between January 2016 and June 2021 were analyzed. Patients were divided into Group 1 (prophylactic replacements every 3 months, n = 41) and Group 2 (at least one spontaneous dislodgement, n = 51). Associations were evaluated for factors including intraabdominal visceral adipose tissue index (IAVATI), subcutaneous adipose tissue index (SATI), and abdominal perimeter. Other variables assessed were Eastern Cooperative Oncology Group (ECOG) performance status scores, psoas muscle index (PMI), renal size, renal parenchymal thickness, renal cortex-to-skin distance, posterolateral abdominal wall muscle thickness, and PCN replacement frequency. Results: No significant differences were identified between Group 1 and Group 2 in IAVATI, SATI, or abdominal perimeter values (p = 0.210–0.412). A significant difference in ECOG performance status scores (p = 0.0001), PMI (p = 0.04) and lower renal size, renal parenchymal thickness, renal cortex-to-skin distance, and posterolateral abdominal muscle thickness (p = 0.0001–0.039) were observed in Group 2. PCN replacements were significantly more frequent in Group 2 (p = 0.0001). Multivariate regression identified renal parenchymal thickness and abdominal wall muscle thickness as significant independent predictors (p = 0.0001, p = 0.02). ROC analysis yielded an AUC of 0.843 (95% CI: 0.769–0.917) for renal parenchymal thickness and 0.694 (95% CI: 0.610–0.778) for abdominal wall muscle thickness. Sensitivity and specificity rates were 73.1% and 96.4% for a 16 mm cutoff in renal parenchymal thickness, and 50.7% and 79.8% for an 8 mm cutoff in abdominal wall muscle thickness. Conclusion: A significant association was identified between spontaneous PCN catheter dislodgement and both the psoas muscle index and ECOG performance status scores, while no notable relationship was observed with abdominal visceral or subcutaneous fat tissue volumes or abdominal perimeter. The risk of dislodgement was found to increase with reduced renal parenchymal and abdominal wall muscle thickness, as well as with more frequent nephrostomy replacements, suggesting these parameters may serve as useful markers for identifying patients at higher risk. Graphical
- 26 February 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 1-15
Open AccessPredictive factors for spontaneous dislodgement of percutaneous nephrostomies for malignant ureteral obstruction
Purpose: To investigate the etiology of spontaneous percutaneous nephrostomy (PCN) catheter dislodgements and evaluate factors potentially associated with these dislodgements, including muscle-to-fat composition and tissue characteristics of catheter traces. Materials and methods: Data from 92 patients (63 males, 29 females; mean age 63.9 ± 11.4 years, range 28–88) undergoing 151 PCN catheter replacements between January 2016 and June 2021 were analyzed. Patients were divided into Group 1 (prophylactic replacements every 3 months, n = 41) and Group 2 (at least one spontaneous dislodgement, n = 51). Associations were evaluated for factors including intraabdominal visceral adipose tissue index (IAVATI), subcutaneous adipose tissue index (SATI), and abdominal perimeter. Other variables assessed were Eastern Cooperative Oncology Group (ECOG) performance status scores, psoas muscle index (PMI), renal size, renal parenchymal thickness, renal cortex-to-skin distance, posterolateral abdominal wall muscle thickness, and PCN replacement frequency. Results: No significant differences were identified between Group 1 and Group 2 in IAVATI, SATI, or abdominal perimeter values (p = 0.210–0.412). A significant difference in ECOG performance status scores (p = 0.0001), PMI (p = 0.04) and lower renal size, renal parenchymal thickness, renal cortex-to-skin distance, and posterolateral abdominal muscle thickness (p = 0.0001–0.039) were observed in Group 2. PCN replacements were significantly more frequent in Group 2 (p = 0.0001). Multivariate regression identified renal parenchymal thickness and abdominal wall muscle thickness as significant independent predictors (p = 0.0001, p = 0.02). ROC analysis yielded an AUC of 0.843 (95% CI: 0.769–0.917) for renal parenchymal thickness and 0.694 (95% CI: 0.610–0.778) for abdominal wall muscle thickness. Sensitivity and specificity rates were 73.1% and 96.4% for a 16 mm cutoff in renal parenchymal thickness, and 50.7% and 79.8% for an 8 mm cutoff in abdominal wall muscle thickness. Conclusion: A significant association was identified between spontaneous PCN catheter dislodgement and both the psoas muscle index and ECOG performance status scores, while no notable relationship was observed with abdominal visceral or subcutaneous fat tissue volumes or abdominal perimeter. The risk of dislodgement was found to increase with reduced renal parenchymal and abdominal wall muscle thickness, as well as with more frequent nephrostomy replacements, suggesting these parameters may serve as useful markers for identifying patients at higher risk. Graphical
- 22 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2426-2439
Role of Superb Microvascular Imaging (SMI) vascularity index values and vascularity patterns in the differential diagnosis of malignant liver lesions
Purpose To evaluate the Superb Microvascular Imaging (SMI) vascular patterns and vascularity index (VI) values of malignant focal liver lesions (FLLs), assess their role in differential diagnosis, and examine interobserver agreement. Materials and methods A total of 107 patients (52 males, 55 females; mean age 62 ± 12.8 years, range 25–87) referred to the interventional radiology clinic for FLL biopsy between April 2022 and April 2023 were analyzed. Two radiologists independently assessed the SMI vascular patterns and calculated VI values. Differences among three lesion groups — hepatocellular carcinoma (HCC, n = 16), non-HCC primary liver malignancies (n = 16), and metastases (n = 75) — were evaluated, and interobserver agreement was assessed. Results Most metastases (88%) demonstrated hypovascular patterns, while HCCs predominantly exhibited hypervascular patterns (68.7–81.3%). Non-HCC primary malignancies showed no dominant vascular pattern. Significant differences in SMI patterns were observed among lesion types (p = 0.001–0.035). VI values for HCCs (7.53–7.73) were significantly higher than those for non-HCC malignancies (2.73–2.93) and metastases (1.35–1.36) (p = 0.0001). ROC analysis based on VI values yielded AUCs of 0.886–0.887, with a cutoff of 2.92 providing 81.3% sensitivity and 79.1–80.2% specificity for HCC diagnosis. The inter-reader agreement for SMI patterns had a kappa score of 0.634, while the intraclass correlation coefficient (ICC) for VI values was 0.959. Conclusion HCCs displayed more hypervascular SMI patterns and significantly higher VI values compared to other malignant FLLs, emphasizing the diagnostic potential of VI in distinguishing HCC from non-HCC tumors. Although metastases primarily exhibited hypovascular patterns and low VI values, no dominant vascular pattern was identified in non-HCC primary liver malignancies. Assessing VI values provided higher interobserver agreement compared to SMI patterns, enhancing objectivity and reproducibility.
- 22 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2426-2439
Role of Superb Microvascular Imaging (SMI) vascularity index values and vascularity patterns in the differential diagnosis of malignant liver lesions
Purpose To evaluate the Superb Microvascular Imaging (SMI) vascular patterns and vascularity index (VI) values of malignant focal liver lesions (FLLs), assess their role in differential diagnosis, and examine interobserver agreement. Materials and methods A total of 107 patients (52 males, 55 females; mean age 62 ± 12.8 years, range 25–87) referred to the interventional radiology clinic for FLL biopsy between April 2022 and April 2023 were analyzed. Two radiologists independently assessed the SMI vascular patterns and calculated VI values. Differences among three lesion groups — hepatocellular carcinoma (HCC, n = 16), non-HCC primary liver malignancies (n = 16), and metastases (n = 75) — were evaluated, and interobserver agreement was assessed. Results Most metastases (88%) demonstrated hypovascular patterns, while HCCs predominantly exhibited hypervascular patterns (68.7–81.3%). Non-HCC primary malignancies showed no dominant vascular pattern. Significant differences in SMI patterns were observed among lesion types (p = 0.001–0.035). VI values for HCCs (7.53–7.73) were significantly higher than those for non-HCC malignancies (2.73–2.93) and metastases (1.35–1.36) (p = 0.0001). ROC analysis based on VI values yielded AUCs of 0.886–0.887, with a cutoff of 2.92 providing 81.3% sensitivity and 79.1–80.2% specificity for HCC diagnosis. The inter-reader agreement for SMI patterns had a kappa score of 0.634, while the intraclass correlation coefficient (ICC) for VI values was 0.959. Conclusion HCCs displayed more hypervascular SMI patterns and significantly higher VI values compared to other malignant FLLs, emphasizing the diagnostic potential of VI in distinguishing HCC from non-HCC tumors. Although metastases primarily exhibited hypovascular patterns and low VI values, no dominant vascular pattern was identified in non-HCC primary liver malignancies. Assessing VI values provided higher interobserver agreement compared to SMI patterns, enhancing objectivity and reproducibility.
- 3 September 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (9) , 1360-1369
Is a two‐hour monitoring period sufficient and safe for patients undergoing ultrasound‐guided percutaneous liver mass biopsy?: A prospective and multicenter experience
Purpose: To investigate whether patients undergoing percutaneous liver mass biopsy (PLMB) can be safely discharged following a two‐hour monitoring period.Methods: A multi‐center prospective analysis was conducted for 375 patients (196 males and 179 females), mean age 63 ± 12.45 years (range 37–89) who underwent PLMB between August 2023 and March 2024. Patients were monitored for 24 h, and complications were classified as minor or major. The timing of complications was categorized into three groups: within the first two hours, between the 2nd and 24th hours, and within 1 week after 24 hours.Results: Minor complications occurred in 18.93% (71/375) and major complications in 2.13% (8/375). Most minor complications (80.2%, 57/71) appeared within the first two hours, 12.7% (9/71) between 2 and 24 h, and 7.1% (5/71) after 24 h. All major complications (62.5%, 5/8) except late‐onset cases, occurred within the first two hours. No major complications occurred between 2 and 24 h. Late‐onset major complications occurred in 37.5% (3/8) after 24 h.Conclusion: The two‐hour monitoring period did not adversely impact patient management regarding minor complications and is safe for identifying all major complications except for late‐onset ones. Extending the post‐biopsy recovery period does not significantly improve patient care.
- 3 September 2024
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (9) , 1360-1369
Is a two‐hour monitoring period sufficient and safe for patients undergoing ultrasound‐guided percutaneous liver mass biopsy?: A prospective and multicenter experience
Purpose: To investigate whether patients undergoing percutaneous liver mass biopsy (PLMB) can be safely discharged following a two‐hour monitoring period.Methods: A multi‐center prospective analysis was conducted for 375 patients (196 males and 179 females), mean age 63 ± 12.45 years (range 37–89) who underwent PLMB between August 2023 and March 2024. Patients were monitored for 24 h, and complications were classified as minor or major. The timing of complications was categorized into three groups: within the first two hours, between the 2nd and 24th hours, and within 1 week after 24 hours.Results: Minor complications occurred in 18.93% (71/375) and major complications in 2.13% (8/375). Most minor complications (80.2%, 57/71) appeared within the first two hours, 12.7% (9/71) between 2 and 24 h, and 7.1% (5/71) after 24 h. All major complications (62.5%, 5/8) except late‐onset cases, occurred within the first two hours. No major complications occurred between 2 and 24 h. Late‐onset major complications occurred in 37.5% (3/8) after 24 h.Conclusion: The two‐hour monitoring period did not adversely impact patient management regarding minor complications and is safe for identifying all major complications except for late‐onset ones. Extending the post‐biopsy recovery period does not significantly improve patient care.